Advertisement

Topics

Idorsia’s ACT-541468 meets primary endpoint in adult and elderly patients with insomnia

07:34 EDT 31 Jul 2017 | thePharmaLetter

Swiss biotech firm Idorsia has released positive results for the comprehensive Phase II program with…

Original Article: Idorsia’s ACT-541468 meets primary endpoint in adult and elderly patients with insomnia

NEXT ARTICLE

More From BioPortfolio on "Idorsia’s ACT-541468 meets primary endpoint in adult and elderly patients with insomnia"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...